Investment House LLC lessened its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 3,269 shares of the biotechnology company’s stock after selling 67 shares during the quarter. Investment House LLC’s holdings in Biogen were worth $846,000 as of its most recent SEC filing. […]
Investment House LLC reduced its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,269 shares of the biotechnology company’s stock after selling 67 shares during the quarter. Investment House LLC’s holdings in […]
Biogen (NASDAQ:BIIB – Free Report) had its target price trimmed by Barclays from $215.00 to $200.00 in a report published on Thursday morning, Benzinga reports. They currently have an equal weight rating on the biotechnology company’s stock. BIIB has been the topic of several other research reports. Wedbush upped their target price on Biogen from […]
Gitterman Wealth Management LLC purchased a new stake in Biogen Inc. (NASDAQ:BIIB – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 980 shares of the biotechnology company’s stock, valued at approximately $254,000. Other institutional investors have also added to or reduced […]
Intellectus Partners LLC lessened its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,563 shares of the biotechnology company’s stock after selling 50 shares during the quarter. Intellectus Partners LLC’s holdings in Biogen […]